WithdrawnPhase 3NCT00000741

The Safety and Effectiveness of Methylprednisolone in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Children With AIDS

Studying Pneumocystosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Principal Investigator
Dankner WM
Intervention
Methylprednisolone(drug)
Eligibility
2 years · All sexes

Study locations (6)

Collaborators

Upjohn

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00000741 on ClinicalTrials.gov

Other trials for Pneumocystosis

Additional recruiting or active studies for the same condition.

See all trials for Pneumocystosis

← Back to all trials